Patients | \nIndications | \nDosage | \nDuration (Days) | \n
Adolescents and Adults (13 years and older) | \nPharyngitis/tonsillitis | \n250 mg twice daily | \n5-10 | \n
Acute bacterial maxillary sinusitis | \n250 mg twice daily | \n10 | \n|
Acute bacterial exacerbations of chronic bronchitis | \n250-500 mg twice daily | \n10 | \n|
Secondary bacterial infections of acute bronchitis | \n250-500 mg twice daily | \n5-10 | \n|
Uncomplicated skin and skin-structureinfections | \n250-500 mg twice daily | \n10 | \n|
Uncomplicated urinary tract infections | \n250 mg twice daily | \n7-10 | \n|
Uncomplicated gonorrhea | \n1000 mg | \nSingle Dose | \n|
Community acquired pneumonia | \n250-500 mg twice daily | \n5-10 | \n|
MDR Typhoid fever | \n500 mg twice daily | \n10-14 | \n|
Lyme disease | \n500 mg twice daily | \n20 | \n|
Pediatric Patients(3 months to 12 years) | \nPharyngitis/tonsillitis | \n20 mg/kg/day in 2 divided dose | \n5-10 | \n
Acute otitis media | \n30 mg/kg/day in 2 divided dose | \n10 | \n|
Acute bacterial maxillary sinusitis | \n30 mg/kg/day in 2 divided dose | \n10 | \n|
Uncomplicated skin & skin-structure infections | \n30 mg/kg/day in 2 divided dose | \n10 | \n|
Community acquired pneumonia | \n30 mg/kg/day in 2 divided dose | \n5-10 | \n|
MDR Typhoid fever | \n30 mg/kg/day in 2 divided dose | \n10-14 | \n|
Uncomplicated urinary tract infection | \n20 mg/kg/day in 2 divided dose | \n7-10 | \n
0 Items
0 Items
Your purchase will delivered in 1 shipment
Your shopping bag is empty. Start shopping now.